Promising Phase 2a data announced for izicopan, underscoring its potential as a meaningfully differentiated, effective and ...

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.

The cancer drug tazemetostat (Tazverik) is being voluntarily withdrawn in the U.S. and all other markets over concerns about secondary cancers, drugmaker Ipsen announced. The company also said it is ...

There are two main goals of antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis (AAV) treatment. The first goal is to bring the condition into remission by controlling active ...

Chronic lung disease is associated with a higher risk for infection in patients with ANCA-associated vasculitis during both induction and maintenance treatment.

While there is no cure for ANCA-associated vasculitis (AAV), treatment is usually very effective at bringing it under control and preventing life-threatening complications. This group of rare ...

Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, causes inflammation of the blood vessels and can affect many parts of the body, including multiple organs. Because of this, ...

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) comes with a heavy quality-of-life burden that doesn't disappear after the early disease phase. This rare but heterogeneous ...

Colorado resident Heston Gray thought he was dealing with a bad sinus infection. "My joints were really stiff. I was having trouble going up and down stairs," recalled Gray. "It just kept getting ...